Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young womenYuemei Hu, Ningshao Xia, Wengang He et al.|Science China Life Sciences|2019Cited by 52
The variations in the natural history of high‐risk <scp>human papillomavirus</scp> infections in Chinese healthy women aged 27–45 years compared with 18–26 years: A prospective cohort studyQi Chen, Ningshao Xia, Xingmei Yao et al.|International Journal of Cancer|2024Cited by 6